Calvin Sternick

Stock Analyst at JP Morgan

(1.89)
# 3,189
Out of 5,072 analysts
19
Total ratings
38.46%
Success rate
5.42%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $73.94
Upside: +48.77%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $39.46
Upside: +102.74%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $32.16
Upside: -16.04%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $244.18
Upside: -25.46%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $217.42
Upside: -62.74%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $148.33
Upside: +164.28%